Home » Newsletters » BioWorld Science

BioWorld Science

June 22, 2005

View Archived Issues

Clinical trials confirm the therapeutic benefits of rasagiline in PD

Hematide shows promise in the treatment of anemia

Crotavirin: potential therapeutic for infectious endocarditis

In vivo and in vitro studies of CHIR-258 for colon cancer

Pre- and postmeal insulin glulisine reduces insulin dose and body weight in type 1 diabetes

Lilly/Alkermes inhaled insulin system achieves blood sugar levels similar to injected insulin

Clinical trials confirm the benefits of conivaptan in patients with hyponatremia

Phase I study for KB-2115 for obesity and dyslipidemia

Recordati buys back U.K. rights to Zanidip

GSK's acquisition of Corixa one step closer

Sosei cleared to begin U.K. phase II study for SOU-001

Phase Ib study for novel quinolone antibiotic TG-873870

U.S. labeling changes, new distribution program for Iressa

Adenoscan launched in Japan

New phase I study for inhaled long-acting muscarinic antagonist for COPD

PLAC test approved to predict risk for ischemic stroke

Helsinn licenses netupitant from Roche

Novartis completes acquisition of Hexal

Issues raised during European review of Endeavor drug-eluting coronary stent

Abiogen and Oryx sign licensing agreement for disodium clodronate

Morphochem provides novel lead compounds for Novartis

Seattle Genetics licenses ADC technology to PSMA Development Company

Fast track status for Fodosine in relapsed or refractory T-cell leukemia

First phase II data on the efficacy of abatacept in multiple sclerosis

CoFactor improves response to 5-fluorouracil in patients with metastatic colorectal cancer

Novel immunomodulatory agents in early development

Recent patents disclose novel agents for treating diabetes

Anti-HCV drugs reported in recent patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...